Pliant Therapeutics, Inc. (PLRX)

Price & Market Data

Price: $1.19

Daily Change: -$0.01 / 0.84%

Daily Range: $1.17 - $1.22

Market Cap: $73,059,307

Daily Volume: 269,369

Performance Metrics

1 Week: -2.48%

1 Month: -9.23%

3 Months: 1.72%

6 Months: -26.25%

1 Year: -19.73%

YTD: -3.28%

About Pliant Therapeutics, Inc. (PLRX)

Dive into the latest financial snapshot of Pliant Therapeutics, Inc. (PLRX). With a current trading price of 1.19, the stock has experienced a daily shift of -$0.01 / 0.84%. The company's market capitalization stands impressively at 73,059,307. Track its year-to-date performance, which is at -3.28%, alongside its weekly, monthly, and yearly trends.

Company Details

Employees: 49

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Selected stocks

Eightco Holdings Inc. (ORBS)

Riverview Bancorp Inc (RVSB)

Acco Group Holdings Limited (ACCL)

Ellington Credit Company (EARN)

Fuel Tech, Inc. (FTEK)